"tyrosine kinase" trang 9 - tải miễn phí từ tailieunhanh
Chemotherapy-induced Takotsubo cardiomyopathy, a case report and review of the literature

Chemotherapy-induced Takotsubo cardiomyopathy, a case report and review of the literature
5    32    1
Regulation of CNKSR2 protein stability by the HECT E3 ubiquitin ligase Smurf2, and its role in breast cancer progression

Regulation of CNKSR2 protein stability by the HECT E3 ubiquitin ligase Smurf2, and its role in breast cancer progression
19    48    1
Erlotinib treatment after platinum-based therapy in elderly patients with non-smallcell lung cancer in routine clinical practice – results from the ElderTac study

Erlotinib treatment after platinum-based therapy in elderly patients with non-smallcell lung cancer in routine clinical practice – results from the ElderTac study
11    42    1
Apatinib for advanced sarcoma: Results from multiple institutions’ off-label use in China

Apatinib for advanced sarcoma: Results from multiple institutions’ off-label use in China
10    60    1
Tumour content ratio matters for detecting epidermal growth factor receptor mutation by cobas test in small biopsies; a retrospective study

Tumour content ratio matters for detecting epidermal growth factor receptor mutation by cobas test in small biopsies; a retrospective study
8    59    1
Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution

Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution
10    33    1
Harnessing soft tissue sarcoma with lowdose pazopanib – a matter of blood levels

Harnessing soft tissue sarcoma with lowdose pazopanib – a matter of blood levels
3    24    1
Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: Initial experience of molecularly targeted therapy

Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: Initial experience of molecularly targeted therapy
9    55    1
HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma

HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma
9    66    1
The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: A population-based study

The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: A population-based study
12    26    1
Case report: Primary resistance to osimertinib in erlotinib-pretreated lung adenocarcinoma with EGFR T790 M mutation

Case report: Primary resistance to osimertinib in erlotinib-pretreated lung adenocarcinoma with EGFR T790 M mutation
4    42    1
Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery

Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery
8    41    1
SoLAT (Sorafenib Lenvatinib alternating treatment): A new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer

SoLAT (Sorafenib Lenvatinib alternating treatment): A new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer
12    72    1
Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study

Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study
6    47    1
Safety and tolerability of quizartinib, a FLT3 inhibitor, in advanced solid tumors: A phase 1 dose-escalation trial

Safety and tolerability of quizartinib, a FLT3 inhibitor, in advanced solid tumors: A phase 1 dose-escalation trial
7    38    1
Efficacy of irreversible EGFR-TKIs for the uncommon secondary resistant EGFR mutations L747S, D761Y, and T854A

Efficacy of irreversible EGFR-TKIs for the uncommon secondary resistant EGFR mutations L747S, D761Y, and T854A
10    44    1
Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor

Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor
10    38    1
Validation of an NGS mutation detection panel for melanoma

Validation of an NGS mutation detection panel for melanoma
7    51    1
Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: A randomized, placebo-controlled phase II AIO trial with serum biomarker program

Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: A randomized, placebo-controlled phase II AIO trial with serum biomarker program
13    42    1
Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: A single-institute analysis

Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: A single-institute analysis
7    32    1